Publicaciones en colaboración con investigadores/as de Hospital Costa Del Sol (9)

2024

  1. The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers

    Journal of Clinical Investigation, Vol. 134, Núm. 8

2022

  1. DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks)

    Viruses, Vol. 14, Núm. 3

2017

  1. Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 3, pp. 487-494

2014

  1. Clinical and virological efficacy of etravirine plus two active nucleos(t)ide analogs in an heterogeneous HIV-infected population

    PLoS ONE, Vol. 9, Núm. 5

2008

  1. Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903

    Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092

2006

  1. Impacto de los factores demográficos y psicosociales en la no adherencia a los fármacos antirretrovirales

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 24, Núm. 6, pp. 373-378

2005

  1. Clinical status, adherence to HAART and quality of life in HIV-infected patients receiving antiretroviral treatment

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 10, pp. 581-585

  2. Health-related quality of life of patients with HIV: Impact of sociodemographic, clinical and psychosocial factors

    Quality of Life Research, Vol. 14, Núm. 5, pp. 1301-1310

  3. Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naïve patients: The VESD study

    HIV Clinical Trials, Vol. 6, Núm. 6, pp. 320-328